Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients.
about
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionRegional gene expression of LOX-1, VCAM-1, and ICAM-1 in aorta of HIV-1 transgenic rats.Current Efavirenz (EFV) or ritonavir-boosted lopinavir (LPV/r) use correlates with elevate markers of atherosclerosis in HIV-infected subjects in Addis Ababa, Ethiopia.Expanding role of circulating adhesion molecules in assessing prognosis and treatment response in human immunodeficiency virus infectionThe association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy.
P2860
Q24550678-6D537EA1-516F-4AFA-BFE3-C6E4B09225B9Q30975430-A4FA93C5-3A40-47F4-AA71-7158A74B5E06Q35542679-A5040175-D1A9-4438-8353-9A6F99B1EB97Q35946434-B6B819B3-72C5-4FF6-BB47-5C84068DCE26Q37355492-9DFE281F-DE0B-4865-A906-E30A4EDD9E44Q43967318-DB75ED5C-9376-4766-B5EA-E515D1193C14Q46431385-48D3F1BF-2F0B-4FE5-9F86-4DF7C8EC95B2
P2860
Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Changes in circulating levels ...... nt of HIV-1-infected patients.
@en
Changes in circulating levels ...... nt of HIV-1-infected patients.
@nl
type
label
Changes in circulating levels ...... nt of HIV-1-infected patients.
@en
Changes in circulating levels ...... nt of HIV-1-infected patients.
@nl
prefLabel
Changes in circulating levels ...... nt of HIV-1-infected patients.
@en
Changes in circulating levels ...... nt of HIV-1-infected patients.
@nl
P2093
P50
P356
P1433
P1476
Changes in circulating levels ...... ent of HIV-1-infected patients
@en
P2093
P304
P356
10.1006/CLIM.2000.4865
P577
2000-06-01T00:00:00Z